Israel Englander Novo Nordisk A S Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Millennium Management LLC holds 165,600 shares of NVO stock, worth $17.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

165,600

Previous 199,100 16.83%

Holding current value

$17.4 Million

Previous $28.4 Million 30.62%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $173 Million - $212 Million	-1,456,141 Reduced 67.24%	709,464 $84.5 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $227 Million - $272 Million	1,852,828 Added 592.38%	2,165,605 $309 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $68.4 Million - $91 Million	-669,637 Reduced 68.16%	312,777 $40.2 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $33 Million - $39.6 Million	375,577 Added 61.89%	982,414 $102 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $14.9 Million - $16.4 Million	95,273 Added 18.62%	606,837 $98.2 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $201 Million - $242 Million	-1,519,989 Reduced 74.82%	511,564 $81.4 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $115 Million - $151 Million	1,116,580 Added 122.03%	2,031,553 $275 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $34 Million - $41.7 Million	-356,891 Reduced 28.06%	914,973 $91.2 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $113 Million - $134 Million	1,096,564 Added 625.54%	1,271,864 $142 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $6.03 Million - $7.28 Million	-64,723 Reduced 26.97%	175,300 $19.5 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $52.7 Million - $64.3 Million	-549,369 Reduced 69.59%	240,023 $26.9 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $65.6 Million - $82.9 Million	777,317 Added 6437.41%	789,392 $75.8 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $23 Million - $28.8 Million	-339,334 Reduced 96.56%	12,075 $1.01 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $17.4 Million - $19.6 Million	259,052 Added 280.49%	351,409 $23.7 Million
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $37.7 Million - $49.4 Million	-761,986 Reduced 89.19%	92,357 $5.56 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $20.7 Million - $24.2 Million	416,138 Added 94.96%	854,343 $49.4 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $6.49 Million - $7.29 Million	-136,456 Reduced 23.75%	438,205 $22.7 Million
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $6.02 Million - $6.75 Million	-128,623 Reduced 18.29%	574,661 $29.3 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $2.51 Million - $2.81 Million	-53,558 Reduced 7.08%	703,284 $28.3 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $3.33 Million - $3.79 Million	-71,929 Reduced 8.68%	756,842 $39.6 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $11.1 Million - $12.6 Million	266,026 Added 47.27%	828,771 $38.2 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $20.4 Million - $22.3 Million	436,077 Added 344.27%	562,745 $26.5 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $3.36 Million - $3.83 Million	75,956 Added 149.78%	126,668 $5.84 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $13.7 Million - $16.4 Million	-282,937 Reduced 84.8%	50,712 $2.5 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $12 Million - $13.6 Million	252,844 Added 312.91%	333,649 $17.9 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $3.33 Million - $3.98 Million	80,805	80,805 $3.89 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account